A document from the DHSC has reportedly advised NHS doctors to ration certain medicines after outlining dozens of drugs that are in shortage, as published in a report.
List view / Grid view
Filter the results
A new report has said the majority of the active ingredients used in pharmaceuticals have never been evaluated for environmental risks.
Lonza Pharma & Biotech is the leader in capsule-based solutions and services, proudly offering Capsugel® products.
2 October 2019 | By SUEZ – Ozonia® Ozone Systems
The goal of this webinar is to familiarize companies with the applications and benefits of ozone technology in ultrapure water systems and Ozonia Membrel® electrolytic technology – SUEZ’s ozone product that produces ozone directly from water instead of gaseous air or oxygen.
In February this year the EU Falsified Medicines Directive (FMD) came into effect. Rich Quelch assesses this latest regulatory attempt to rid the supply chain of dangerous falsified products and reflects on the industry’s need to keep ahead of the game to future-protect itself.
Confirming product authenticity, combating counterfeiting and preventing product diversion are key for compliance within the global supply chain. This whitepaper focuses on pharmaceutical serialisation and solutions to combat producers of counterfeit products.
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
Emirates SkyCargo has commenced handling pharmaceutical cargo at a new purpose-built facility in Chicago.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
With the UK bracing itself for a 'no-deal' Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare for it against the upcoming deadline.